Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-11-01
1993-01-05
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, 530317, 530319, 530322, A61K 3710, A61K 3702, C07K 500, C07K 700
Patent
active
051770598
ABSTRACT:
Polymyxin B carrier conjugates, especially polymyxin B-dextran, are water soluble, have a greater half-life in the bloodstream and are significantly less toxic than native polymyxin B.
REFERENCES:
patent: 4766106 (1988-08-01), Katre et al.
Snezhko et al., 1972, Moscow Textile Institute, 1972, pp. 1-8.
Zalipsky et al, Eur. Polym J., vol. 19, No. 12, 1983, pp. 1177-1183.
LaPort et al, Biochemistry, vol. 16, No. 8, 1977, pp. 1642-1648.
Biosis Abstract 85:421296 Kitagawa et al. 1985 "Sensitive Enzyme Immunoassay of Colistin . . . " J. Assoc. Off. Anal. Chem. 68(4):661-664.
Handley Dean A.
Lake Philip
Battle Carl W.
Davenport A. M.
Honor Robert S.
Lee Lester L.
Sandoz Ltd.
LandOfFree
Polymyxin B conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymyxin B conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymyxin B conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390635